Endothelial Integrin‐Linked Kinase (ILK) Deficiency Promotes Endothelial Activation and Cardiovascular Dysfunction via Receptor Interacting Protein Kinase‐1 (RIPK1) Enriched‐Extracellular Vesicle Signalling
Journal of Extracellular Vesicles · 2026-06 · 15 (6)
DOI: 10.1002/jev2.70335 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, online erschienen am 23.06.2026. Verfasst von Alberto Cook-Calvete und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Systems Biology, Universidad de Alcalá, Alcalá de Henares, Madrid, Spain. Hauptthemen laut MEDLINE: Receptor-Interacting Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases, Extracellular Vesicles, Endothelial Cells. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Instituto de Salud Carlos III, European Union, Junta de Comunidades de Castilla La Mancha (JCCM)/INNOCAM-EDRF/FEDER.
Abstract (Originalsprache)
Integrin‐linked kinase (ILK) maintains endothelial homeostasis by supporting endothelial nitric oxide synthase activity and restraining vascular inflammation. Although endothelial ILK loss is linked to vascular and cardiac disease, the mechanisms driving progression remain unclear. We hypothesized that extracellular vesicles (EVs) released by ILK‐deficient endothelial cells propagate endothelial activation and cardiac dysfunction. In endothelial‐specific ILK conditional knockout mice, ILK loss induced rapid endothelial activation, marked by increased iNOS, VCAM‐1 and ICAM‐1, followed by perivascular macrophage accumulation and chronic cardiac inflammation. In vitro, ILK‐deficient endothelial cells exhibited barrier dysfunction, NF‐κB activation and increased chemokine production. EVs derived from ILK deficient cells were enriched in pro‐inflammatory cargo, including receptor‐interacting protein kinase 1 (RIPK1), and transferred the activation phenotype to naïve endothelial cells. RIPK1 inhibition in recipient cells or RIPK1 silencing in donor cells abolished EV‐induced activation, thereby confirming a necessary role for RIPK1. Endothelial ILK‐deficient mice also exhibited increased circulating EVs enriched in endothelial activation markers and RIPK1. Transfer of these EVs to wild type mice induced coronary endothelial activation, macrophage recruitment, microvascular remodelling, cardiac fibrosis, and ventricular dysfunction mimicking the phenotype of the donor mice. RIPK1‐dependent inflammatory effects were similarly observed with EVs from atherosclerotic ApoE − / − mice and patients with coronary artery disease. These findings reveal an ILK–RIPK1 EV signalling axis that propagates vascular inflammation and promotes cardiac dysfunction, establishing a conserved pathogenic mechanism operative in experimental models and in human coronary artery atherosclerosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Systems Biology, Universidad de Alcalá, Alcalá de Henares, Madrid, Spain.
- Ramón y Cajal Institute for Health Research (IRYCIS), Madrid, Madrid, Spain.
- Department of Cardiac Surgery, Ramón y Cajal Hospital, Madrid, Madrid, Spain.
- Programa de Doctorado en Ciencias de la Salud, Universidad de Alcalá, Alcalá de Henares, Madrid, Spain.
- Cardiovascular Diseases Research Network Center (CIBERCV), Madrid, Madrid, Spain.
- Francisco de Vitoria University, Pozuelo de Alarcón, Madrid, Spain.
ORCID-Profile: José López-Menendez, Carlos Zaragoza, Marta Saura
Förderung
- Instituto de Salud Carlos III
- European Union
- Junta de Comunidades de Castilla La Mancha (JCCM)/INNOCAM-EDRF/FEDER
- Comunidad de Madrid, Biomedicine Activities Program
- Ministerio de Ciencia, Innovación y Universidades/EDRF a way to making Europe
- European Commission
Zitieren
APA
Cook-Calvete, A., Delgado-Marín, M., Jorquera Ortega, S., Moreta, S., Castro-Pinto, M., López-Menendez, J., Fernandez-Rodríguez, B., García-García, J., Zaragoza, C., & Saura, M. (2026). Endothelial Integrin‐Linked Kinase (ILK) Deficiency Promotes Endothelial Activation and Cardiovascular Dysfunction via Receptor Interacting Protein Kinase‐1 (RIPK1) Enriched‐Extracellular Vesicle Signalling. Journal of Extracellular Vesicles, 15(6). https://doi.org/10.1002/jev2.70335
Vancouver
Cook-Calvete A, Delgado-Marín M, Jorquera Ortega S, Moreta S, Castro-Pinto M, López-Menendez J, et al. Endothelial Integrin‐Linked Kinase (ILK) Deficiency Promotes Endothelial Activation and Cardiovascular Dysfunction via Receptor Interacting Protein Kinase‐1 (RIPK1) Enriched‐Extracellular Vesicle Signalling. Journal of Extracellular Vesicles. 2026;15(6). doi:10.1002/jev2.70335
BibTeX
@article{CookCalvete2026,
author = {Cook-Calvete, Alberto and Delgado-Marín, María and Jorquera Ortega, Sara and Moreta, Silvia and Castro-Pinto, Mercedes and López-Menendez, José and Fernandez-Rodríguez, Blanca and García-García, Julia and Zaragoza, Carlos and Saura, Marta},
title = {Endothelial Integrin‐Linked Kinase (ILK) Deficiency Promotes Endothelial Activation and Cardiovascular Dysfunction via Receptor Interacting Protein Kinase‐1 (RIPK1) Enriched‐Extracellular Vesicle Signalling},
journal = {Journal of Extracellular Vesicles},
year = {2026},
volume = {15},
number = {6},
doi = {10.1002/jev2.70335}
}
EUVIMED